$6.73
-0.065-0.96%
Last update: Nov 6, 9:30 AM
Evolus Inc
EOLSNASDAQ
The average analyst price target for Evolus is $17.80, 164.5% above the current price. Of 7 analysts, 6 rate it Buy and 1 Hold. Targets range from $13 to $25. The latest change came on Nov 5, 2026, when BTIG raised its price target on Evolus from $13 to $15 and kept a Buy rating.
Price Target Range — 13 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months
